MARK HASLETON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ORAMED PHARMACEUTICALS INC.

Filing Date Source Excerpt
2019-08-06 Dr. Hasleton holds a PhD in molecular biology and cancer research from the Imperial College London, UK, a master of research in molecular biology from the University of Manchester, UK and a master of business administration from Tanaka Business School, Imperial College London, UK.

Data sourced from SEC filings. Last updated: 2026-02-03